- Release Date: 12/09/23 09:16
- Summary: Ethics Approval Received for Phase 2 Trial
- Price Sensitive: Yes
- Download Document 281.35KB
- Forums
- ASX - By Stock
- Ann: Ethics Approval Received for Phase 2 Trial
AGN
argenica therapeutics limited
Add to My Watchlist
1.56%
!
31.5¢

Ann: Ethics Approval Received for Phase 2 Trial
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
31.5¢ |
Change
-0.005(1.56%) |
Mkt cap ! $40.46M |
Open | High | Low | Value | Volume |
32.0¢ | 32.5¢ | 31.0¢ | $36.89K | 116.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7935 | 31.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
33.0¢ | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7935 | 0.315 |
2 | 265148 | 0.310 |
1 | 3278 | 0.305 |
4 | 70336 | 0.300 |
2 | 25000 | 0.295 |
Price($) | Vol. | No. |
---|---|---|
0.330 | 20000 | 1 |
0.335 | 56153 | 2 |
0.350 | 70901 | 4 |
0.355 | 9755 | 1 |
0.375 | 3921 | 1 |
Last trade - 16.10pm 15/09/2025 (20 minute delay) ? |
Featured News
AGN (ASX) Chart |
The Watchlist
FBM
FUTURE BATTERY MINERALS LIMITED
Nick Rathjen, MD & CEO
Nick Rathjen
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online